GERMANY – Biotronik has teamed up with AliveCor to disrupt the cardiac digital health space through the use of artificial intelligence (AI)-based solutions.

The team-up is the “first in a series of strategic partnerships” aimed at bettering the delivery of connected care in cardiac diagnostics and remote patient monitoring, the company said.

The partnership will bring together Biotronik’s Biomonitor injectable cardiac monitor with AliveCor’s AI-enabled, clinically validated, medical-grade KardiaMobile 6L and KardiaMobile Card ECG technology.

Through this pilot collaboration, healthcare providers will be able to access clinically relevant heart rhythm analyses and actionable reports to monitor at-risk patients; identify underlying arrhythmias, including atrial fibrillation (AF); and assess means to drive improvements to patient care and clinical outcomes, Biotronik said in a press release.

Historically, screening options for early atrial fibrillation (AF) detection have been limited,” noted Biotronik.

The company says it has so far been difficult for healthcare providers to access the full range of patient data because information gathered from remote personal monitoring and implantable devices has rarely been integrated.

Through the collaboration, Biotronik says healthcare providers will be able to access clinically relevant heart rhythm analyses and actionable reports to monitor at-risk patients, as well as identify underlying arrhythmias, including Atrial fibrillation (AF), while also determining how best to improve patient care and outcomes.

However, by pairing its BioMonitor injectable cardiac monitor with AliveCor’s KardiaMobile 6L and KardiaMobile Card electrocardiogram (ECG) technology, it hopes to make the task easier for medical professionals by providing them comprehensive visibility within a single solution.

The partnership will bring together Biotronik’s Biomonitor injectable cardiac monitor with AliveCor’s AI-enabled, clinically validated, medical-grade KardiaMobile 6L and KardiaMobile Card ECG technology.

Earlier, AliveCor and Dignio linked up to provide remote ECG monitoring, a move aimed at allowing seamless transmission of electrocardiograms (ECG) recorded by patients in the community direct to clinicians.

Dignio is already working with University Hospitals of Leicester NHS Trust, which is running one of the first virtual wards to monitor and manage patients with Atrial Fibrillation, a project which has created virtual beds.

Atrial fibrillation (AF) patients admitted to hospital experiencing abnormal heart rhythms could spend two or more days in hospital with close monitoring to assess response to the treatment received.

With a ‘connected care’ solution, like Dignio, suitable patients can now stay in the comfort of their own home, surrounded by friends and family whilst reducing the need to be managed in the hospital.

While the KardiaMobile device is a vital part of the ‘at home’ monitoring process, the method for transferring ECG data back to clinicians monitoring patients on the virtual ward can be challenging for some patients.

Now the MyDignio app and KardiaMobile have been integrated, making the transfer of data much easier and faster.

The MyDignio app, automatically sends a patient’s readings direct to clinicians via a special data platform.

The app connects, via Bluetooth, to several devices, including blood pressure monitors and pulse oximeters, and now it also connects to KardiaMobile.

Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE